BRPI0414096A - sistema lipìdico e métodos de uso - Google Patents

sistema lipìdico e métodos de uso

Info

Publication number
BRPI0414096A
BRPI0414096A BRPI0414096-6A BRPI0414096A BRPI0414096A BR PI0414096 A BRPI0414096 A BR PI0414096A BR PI0414096 A BRPI0414096 A BR PI0414096A BR PI0414096 A BRPI0414096 A BR PI0414096A
Authority
BR
Brazil
Prior art keywords
omega
lipid system
fatty acids
methods
present
Prior art date
Application number
BRPI0414096-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Vikkie A Mustad
Stephen Demichele
Bradley A Zinker
Yung-Sheng Huang
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of BRPI0414096A publication Critical patent/BRPI0414096A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Pediatric Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Edible Oils And Fats (AREA)
  • Medicinal Preparation (AREA)
BRPI0414096-6A 2003-09-05 2004-08-04 sistema lipìdico e métodos de uso BRPI0414096A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/656,662 US7759507B2 (en) 2003-09-05 2003-09-05 Lipid system and methods of use
PCT/US2004/025161 WO2005025334A1 (en) 2003-09-05 2004-08-04 Lipid system and methods of use

Publications (1)

Publication Number Publication Date
BRPI0414096A true BRPI0414096A (pt) 2006-10-31

Family

ID=34226392

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414096-6A BRPI0414096A (pt) 2003-09-05 2004-08-04 sistema lipìdico e métodos de uso

Country Status (13)

Country Link
US (2) US7759507B2 (enExample)
EP (1) EP1662905A1 (enExample)
JP (1) JP5745734B2 (enExample)
KR (1) KR20060076766A (enExample)
CN (1) CN1874692B (enExample)
AU (2) AU2004271928B2 (enExample)
BR (1) BRPI0414096A (enExample)
CA (1) CA2536692C (enExample)
IL (1) IL173967A (enExample)
MX (1) MXPA06002481A (enExample)
NZ (1) NZ545470A (enExample)
WO (1) WO2005025334A1 (enExample)
ZA (1) ZA200602768B (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344747B2 (en) * 2004-04-29 2008-03-18 Gfa Brands, Inc. Oxidative stabilization of omega-3 fatty acids in low linoleic acid-containing peanut butter
US20060083824A1 (en) * 2004-10-20 2006-04-20 Pbm Products Llc Nutritional supplements for glucose intolerant individuals
BRPI0614417A2 (pt) * 2005-07-28 2011-03-29 Reliant Pharmaceuticals Inc composições farmacêuticas compreendendo bloqueadores de canais de cálcio de dihidropiridina e ácidos graxos de Èmega-3 e métodos de tratamento utilizando as mesmas
US20070166411A1 (en) * 2005-12-16 2007-07-19 Bristol-Myers Squibb Company Nutritional supplement containing long-chain polyunsaturated fatty acids
JP5158715B2 (ja) * 2006-05-16 2013-03-06 独立行政法人産業技術総合研究所 平滑筋収縮抑制剤
WO2008081754A1 (ja) * 2006-12-28 2008-07-10 The Nisshin Oillio Group, Ltd. 油脂組成物および該油脂組成物を含有する飲食物
US20090270502A1 (en) * 2007-01-11 2009-10-29 Carotino Sdn. Bhd. Method for Lowering Risk of Cardiovascular Diseases
US20080207748A1 (en) * 2007-02-22 2008-08-28 Innovation Labs, Inc. Vitamin c preparation
US20080269328A1 (en) * 2007-04-09 2008-10-30 Mohammed Moghadasian Effects of low n-6:n-3 fatty acid ratio from two dietary sources on plasma and tissue lipid composition
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
WO2009058799A1 (en) * 2007-11-01 2009-05-07 Wake Forest University School Of Medicine Compositions and methods for prevention and treatment of mammalian diseases
US20090155447A1 (en) * 2007-12-12 2009-06-18 Solae, Llc Protein extrudates comprising omega-3 fatty acids
US20110177224A1 (en) * 2008-03-03 2011-07-21 Daniel Perlman Stabilization of omega-3 fatty acids in oil-water emulsions
US20090264520A1 (en) * 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
US20100130608A1 (en) * 2008-10-01 2010-05-27 Martek Biosciences Corporation Compositions and methods for reducing triglyceride levels
JP5407362B2 (ja) * 2009-01-26 2014-02-05 株式会社カネカ 水中油型乳化油脂組成物
AU2010230362B2 (en) * 2009-04-01 2015-01-15 Société des Produits Nestlé S.A. Reduction of risk of obesity
US20100272875A1 (en) * 2009-04-24 2010-10-28 Monsanto Technology Llc Omega-3 enriched cereal, granola, and snack bars
JP2009219500A (ja) * 2009-06-22 2009-10-01 Suntory Holdings Ltd 血管の老化に起因する症状あるいは疾患の予防又は改善作用を有する組成物
US11986508B1 (en) 2010-04-06 2024-05-21 Juliana Konzny Nutritional and cosmetic product, system and method for use
CN101843336A (zh) * 2010-04-22 2010-09-29 王京南 亚麻油脂肪乳口服溶液、饮料及制造方法
MX2013009007A (es) 2011-02-02 2013-08-29 Nestec Sa Composiciones nutricionales altas en proteina y metodos para elaborar y utilizar las mismas.
US10682327B2 (en) 2011-04-17 2020-06-16 Omega Foods, LLC Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids
CA3203958A1 (en) * 2011-04-17 2012-10-26 Omega Foods, LLC Omega-6/omega-3 balanced polyunsaturated fatty acids composition
WO2012145119A2 (en) * 2011-04-17 2012-10-26 Michael Gurin Low inflammatory blended oils
US10653160B2 (en) 2011-04-17 2020-05-19 Omega Foods, LLC Prepared foods having high efficacy omega 6/omega 3 balanced polyunsaturated fatty acids
US20210176999A1 (en) 2011-04-17 2021-06-17 Omega Foods, LLC Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids
JP6399655B2 (ja) 2012-01-06 2018-10-03 オムセラ・ファーマシューティカルズ・インコーポレイテッド 遊離酸型のオメガ−３多価不飽和脂肪酸のｄｐａ濃縮組成物
US8551551B2 (en) 2012-01-06 2013-10-08 Perlman Consulting, Llc Stabilization of omega-3 fatty acids in saturated fat microparticles having low linoleic acid content
US9492545B2 (en) 2012-05-07 2016-11-15 Omthera Pharmaceuticals Inc. Compositions of statins and omega-3 fatty acids
WO2013186233A1 (en) * 2012-06-12 2013-12-19 Norwegian University Of Science And Technology Composition
BR112015001884B1 (pt) * 2012-07-31 2020-12-01 Société des Produits Nestlé S.A. composição nutricional para promover a saúde musculoesquelética em pacientes com doença inflamatória intestinal (ibd), seu uso, e formulação farmacêutica, formulação nutricional, formulação de alimentação por tubo, suplemento alimentar, alimento funcional ou produto de bebida
CN104247786A (zh) * 2013-06-26 2014-12-31 孙志刚 一种正营养动植物油混合健康双合食用油
CN104247787A (zh) * 2013-06-26 2014-12-31 孙志刚 一种正营养动植物油混合普健康经济型a级双合食用油
CN104413168A (zh) * 2013-08-20 2015-03-18 孙志刚 一种日摄入量30-35克人群24种正营养食用油各种健康指标的脂肪酸科学配比
CN104413170A (zh) * 2013-08-20 2015-03-18 孙志刚 一种日摄入量25-30克人群24种正营养食用油各种健康指标的脂肪酸科学配比
CN104413167A (zh) * 2013-08-20 2015-03-18 孙志刚 一种日摄入量35克以上人群24种正营养食用油各种健康指标的脂肪酸科学配比
EP3190099B1 (de) 2015-09-14 2020-10-28 Helmholtz-Zentrum Potsdam - Deutsches GeoForschungsZentrum GFZ Stiftung des Öffentlichen Rechts des Lands Brandenburg Neue fettsäure und ihre verwendung
BR102016016559A2 (pt) * 2016-07-18 2018-02-06 Francisco Pianowski Luiz Apresentação de cloreto de magnésio ingerível
AU2023331991A1 (en) * 2022-09-01 2025-03-20 ETH Zürich Lipid emulsion with anti-inflammatory effects for total parenteral and enteral nutrition
CN116058417A (zh) * 2022-11-25 2023-05-05 新疆札郎孜生物科技有限公司 一种植物调和油及其应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8302708D0 (en) 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
US4526902A (en) 1983-10-24 1985-07-02 Century Laboratories, Inc. Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions
US4921877A (en) 1986-10-27 1990-05-01 Abbott Laboratories Liquid nutritional formula for glucose intolerance
GB8819110D0 (en) 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
US6140304A (en) 1988-09-28 2000-10-31 Eicotech Corporation Method of and nutritional and pharmaceutical compositions for reduction of hyperinsulinemia
US5059622A (en) 1989-08-29 1991-10-22 Biosyn, Inc. Method for reducing blood pressure levels in hypertensive persons
GB2223943A (en) 1988-10-21 1990-04-25 Tillotts Pharma Ag Oral disage forms of omega-3 polyunsaturated acids
US5922345A (en) 1990-12-07 1999-07-13 Scotia Holdings Plc Nutrition
US5308832A (en) 1992-07-27 1994-05-03 Abbott Laboratories Nutritional product for persons having a neurological injury
JPH0745616A (ja) * 1993-07-29 1995-02-14 Nec Corp 半導体装置の製造方法
DE69326949T2 (de) 1993-08-20 2000-02-17 Societe Des Produits Nestle S.A., Vevey Lipidzusammensetzung für Nahrungsmittel
NZ281878A (en) 1994-04-01 1997-02-24 Abbott Lab Nutritional product for enteral feeding containing indigestible carbohydrate, an oil blend and optionally protein and other nutrients; used to treat colitis
US5780451A (en) 1994-04-01 1998-07-14 Abbott Laboratories Nutritional product for a person having ulcerative colitis
US5952314A (en) 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
DE4417851C1 (de) 1994-05-20 1995-10-05 Horst Heirler Diätetisches Lebensmittel mit mittelkettigen Fettsäuren und dessen Verwendung
JP3840670B2 (ja) 1995-01-27 2006-11-01 味の素株式会社 糖尿病患者用脂肪輸液剤
US5895652A (en) 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
US5922704A (en) 1997-12-24 1999-07-13 Feeling Fine Company Llc Optimal nutritional supplement for men
WO1999062359A1 (en) 1998-06-03 1999-12-09 State Of Israel Ministry Of Agriculture Agriculture Research Organization The Volkani Center Matthiola seed oil, mixtures containing it and use thereof
WO2000012179A1 (en) 1998-08-27 2000-03-09 Bowles Fluidics Corporation Water bottle with drinking and spray modes
JP3998355B2 (ja) * 1998-11-26 2007-10-24 日清オイリオグループ株式会社 食用油
AUPQ228199A0 (en) 1999-08-18 1999-09-09 Sly, Anthony William Ophthalmic fluid
JP4391673B2 (ja) * 2000-08-08 2009-12-24 花王株式会社 油脂組成物
CA2418350C (en) 2000-08-08 2010-01-19 Kao Corporation Oil/fat composition
AU2001236616A1 (en) 2000-08-26 2002-03-13 Metagenics, Inc. Improved stability conjugated linoleic acid composition for dietary supplement and food uses
DE60104450T2 (de) * 2000-09-21 2005-09-15 Nutrition 21, Inc. Chrom enthaltende zusammensetzung zur behandlung von diabetes, zur verbesserung der insulinsensitivität und zur reduktion von hyperglykämie, hypercholesterolämie und des körperfettanteils
DE10130491A1 (de) * 2001-06-25 2003-04-17 Heirler Horst Verwendung von mittelkettigen Triglyceriden zur Prävention und Therapie von Adipositas
CN1339262A (zh) 2001-09-21 2002-03-13 阮生 食用香油

Also Published As

Publication number Publication date
WO2005025334A1 (en) 2005-03-24
AU2004271928A1 (en) 2005-03-24
IL173967A (en) 2012-04-30
US20080039525A1 (en) 2008-02-14
AU2004271928B2 (en) 2011-04-14
KR20060076766A (ko) 2006-07-04
CA2536692A1 (en) 2005-03-24
IL173967A0 (en) 2006-07-05
ZA200602768B (en) 2007-09-26
US7601757B2 (en) 2009-10-13
US7759507B2 (en) 2010-07-20
CA2536692C (en) 2013-04-16
US20050054724A1 (en) 2005-03-10
MXPA06002481A (es) 2006-06-20
NZ545470A (en) 2009-06-26
JP2007504225A (ja) 2007-03-01
CN1874692A (zh) 2006-12-06
CN1874692B (zh) 2011-10-19
AU2011201489A1 (en) 2011-04-21
JP5745734B2 (ja) 2015-07-08
EP1662905A1 (en) 2006-06-07

Similar Documents

Publication Publication Date Title
BRPI0414096A (pt) sistema lipìdico e métodos de uso
ATE402143T1 (de) Verfahren zum erhalten neuer formulierungen auf luteinbasis
HN2002000275A (es) Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados
EP4509118A3 (en) High-purity peg lipids and uses thereof
GB2459809A (en) Fatty acid formulations and methods of use thereof
PA8481501A1 (es) 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
HRP20040474B1 (hr) Farmaceutske formulacije koje sadrže modifikator imunog odgovora
CY1108700T1 (el) Συνθεσεις απελευθερωσης φαρμακου εστερα αλφα-υδροξυ οξεος και μεθοδοι χρησης
AR039170A1 (es) Co-granulos de dha y romero y metodos de uso
PT1093819E (pt) Compostos e composicoes para fornecimento de agentes activos
BR0014087A (pt) Composições com pérolas de caroteno - xantofila estáveis e métodos de uso
TW200744463A (en) Nutritional supplement containing long-chain polyunsaturated fatty acids
WO2006012502A3 (en) Formulation of insoluble small molecule therapeutics in lipid-based carriers
EA200970238A1 (ru) ПРИМЕНЕНИЕ МАСЕЛ С DPA(n-6) В ДЕТСКОМ ПИТАНИИ
WO2009055568A3 (en) Liposomal vancomycin formulations
BR0311764A (pt) Composição herbicida
FI964285A0 (fi) Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet
WO2003099830A3 (en) Cardiolipin compositions, methods of preparation and use
BRPI0414858A (pt) métodos para preparação de corpos de óleo compreendendo ingredientes ativos
ATE362750T1 (de) Kosmetisches mittel formulierungskit
MX2009012782A (es) Formulaciones para administracion oral de agentes terapeuticos y metodos relacionados.
WO2008070721A3 (en) High protein concentration formulations containing mannitol
BR0308713A (pt) Co-esférula de dha e alecrim, e métodos de uso
BRPI0720230A2 (pt) Uso de uma formulação nutricional oralmente administrável, formulação nutricional, método para tratar um distúrbio desenvolvimental penetrante, e, composição
WO2007111720A8 (en) Formulation of insoluble small molecule therapeutics in lipid-based carriers

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A23L 33/12 (2016.01), A23L 33/00 (2016.01)